APA (7th ed.) Citation

AD, O., J, S., V, P., RL, C., N, E., AM, L., . . . DG, T. (2023). Pepducin ICL1-9-Mediated β2-Adrenergic Receptor-Dependent Cardiomyocyte Contractility Occurs in a Gi Protein/ROCK/PKD-Sensitive Manner. Cardiovascular drugs and therapy, 37(2), 245. https://doi.org/10.1007/s10557-021-07299-4

Chicago Style (17th ed.) Citation

AD, Okyere, et al. "Pepducin ICL1-9-Mediated β2-Adrenergic Receptor-Dependent Cardiomyocyte Contractility Occurs in a Gi Protein/ROCK/PKD-Sensitive Manner." Cardiovascular Drugs and Therapy 37, no. 2 (2023): 245. https://doi.org/10.1007/s10557-021-07299-4.

MLA (9th ed.) Citation

AD, Okyere, et al. "Pepducin ICL1-9-Mediated β2-Adrenergic Receptor-Dependent Cardiomyocyte Contractility Occurs in a Gi Protein/ROCK/PKD-Sensitive Manner." Cardiovascular Drugs and Therapy, vol. 37, no. 2, 2023, p. 245, https://doi.org/10.1007/s10557-021-07299-4.